查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2089004

神經血管介入器材市場：依產品類型、適應症、手術類型和最終用戶分類－2026-2032年全球市場預測

Neurovascular Intervention Devices Market by Product Type, Indication, Procedure Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，神經血管介入器材市場規模將成長至 71.4 億美元，複合年成長率為 6.69%。

主要市場統計數據
基準年 2025 45.3億美元
預計年份：2026年 48.4億美元
預測年份 2032 71.4億美元
複合年成長率 (%) 6.69%

隨著中風和顱內動脈瘤的治療從單純藥物治療轉向時間緊迫、影像引導下的血管內介入治療，神經血管介入器械市場正在不斷擴大。根據世界卒中組織和全球疾病負擔研究的數據，卒中是全球主要的死亡和長期殘疾原因之一，每年新增卒中病例超過1200萬例，卒中相關死亡病例超過600萬例。如此沉重的疾病負擔使得血栓摘取支架、抽吸導管、栓塞彈簧圈、血流導引裝置、囊內裝置、神經血管支架、導線、導管導引線、球囊導管和血管通路系統等器械的臨床需求持續旺盛。

推動其在臨床實踐中應用的主要動力來自隨機對照試驗的證據，這些試驗表明，機械取栓術能夠改善合格的大血管閉塞性中風患者的功能預後。這包括一些在傳統早期治療窗口期之後接受治療的患者，這些患者在透過先進影像學檢查發現可挽救的腦組織時才接受了治療。因此，醫院、醫療設備製造商、臨床醫生和保險公司都在優先考慮那些能夠加快診斷速度、建構更完善的卒中診療網路、提高治療效果、再通率、手術安全性和工作流程效率的神經血管器械。

神經血管裝置領域的變革性變化

微創治療、先進神經影像學和系統化中風診療體系的融合正在重塑神經血管介入器材的格局。機械取栓術正推動急性缺血性腦中風（適用於大血管閉塞病例）的治療轉向快速血管內介入。同時，諸如血流導向術、動脈瘤內栓塞術和輔助支架置入術等新型動脈瘤治療技術，正在拓展複雜動脈瘤、分叉動脈瘤和寬頸顱內動脈瘤的治療選擇。

人工智慧在神經血管醫學領域的累積影響

人工智慧（AI）並非單一技術，而是對神經血管疾病診療的整個流程產生累積影響。經FDA核准的AI驅動的食品藥物管理局診斷工具正日益輔助檢測和分診主要血管閉塞、顱內出血和灌注異常，幫助醫療團隊縮短急性卒中診療流程中的決策週期，涵蓋從轉運到影像檢查、從影像檢查到通知、以及從影像檢查到介入治療決策等各個環節。

主要區域洞察：亞太地區、北美地區、歐洲地區和新興地區

北美地區神經血管介入器材的普及率仍然很高，這得益於其成熟的卒中中心網路、CT血管造影術和灌注成像的廣泛應用、完善的醫保報銷機制以及積極參與神經血管臨床研究。在歐洲，先進的介入神經放射學實踐與醫療設備法規（MDR）下更為嚴格的證據要求相結合，為臨床上具有差異化的血栓切除術、栓塞術和動脈瘤治療技術創造了機遇，這些技術展現出安全性、持久性、易用性和在醫療保健系統中的價值。

主要區域集團分析：東協、海灣合作理事會、歐盟、金磚國家、七國集團、北約

儘管東協市場在加強中風轉診途徑和擴大血管內卒中治療方面取得了進展，但由於報銷模式、都市區醫療資源獲取差異、醫院基礎設施以及介入醫療專業人員的人力資源基礎等方面的差異，新加坡、泰國、馬來西亞、印尼、越南和菲律賓的實施情況存在顯著差異。在海灣合作理事會國家，對三級醫院、數位醫療基礎設施、專家招聘和國際臨床標準的投資，正在推動卓越醫療中心對高品質神經血管技術的需求。

主要神經血管市場的關鍵國家特定趨勢

美國是創新和技術應用的中心，這得益於其完善的卒中中心認證體系、獲得FDA批准的神經血管醫療設備、先進的影像技術和強大的臨床試驗基礎設施。而加拿大則強調各省醫療保健系統內醫療服務的公平獲取以及本地化卒中診療路徑的建立。儘管墨西哥和巴西正在拓展其介入神經放射學能力，但機械取栓術和動脈瘤栓塞術仍主要集中在大型都市區醫院、私人醫院或三級公立醫療機構。

為行業領導者提供的實用建議

產業領導者應優先考慮基於實證醫學的神經血管介入器材差異化。與僅進行漸進式設計改進的器械相比，能夠提高首次試驗再灌注率、縮短手術時間、增強在彎曲解剖結構內的可追蹤性、降低併發症風險並能持續閉塞動脈瘤的產品，將更受臨床實踐的關注。

調查方法

本執行摘要基於一套系統化的調查方法，該方法結合了檢驗的二手研究、監管審查、臨床文獻評估和市場三角驗證。資訊來源包括同行評審的關於中風和介入神經放射學的研究、世界中風組織 (WSO) 和全球疾病負擔 (GBD) 的研究結果、美國食品藥物管理局 (FDA) 和歐洲的監管資訊、醫院診療路徑標準、保險報銷參考資料、臨床指南文件以及公開的醫療基礎設施指標。

結論

隨著醫療系統將快速診斷、微創治療和可衡量的患者療效作為優先事項，神經血管介入器材正成為現代中風和顱內動脈瘤治療的核心。這一趨勢的促進因素包括：腦血管疾病的沉重負擔、血栓切除術對某些主要血管閉塞患者的顯著療效、動脈瘤治療器械的不斷創新，以及人工智慧（AI）在加速基於影像的分流和治療方案調整方面的日益廣泛的應用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：神經血管介入器材市場：依產品類型分類

  • 栓塞劑
    • 液態栓塞劑
    • 顆粒栓子
  • 分流器
    • 管道栓塞裝置
    • 超越流潛水員
  • 微導管
    • 親水塗層
    • 聚合物塗層
  • 神經血管線圈
    • 可拆卸線圈
    • 推式線圈
  • 支架
    • 氣球式
    • 自膨脹
  • 血栓除去裝置
    • 吸力裝置
    • 血栓摘取支架

第8章：神經血管介入器材市場：依適應症分類

  • 動脈瘤
  • 動靜脈畸形
  • 中風

第9章：神經血管介入器械市場：依手術類型分類

  • 栓塞術
  • 流染版
  • 血栓切除術

第10章：神經血管介入器材市場：依最終用戶分類

  • 門診中心
  • 診所
  • 醫院

第11章：神經血管介入器材市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章：神經血管介入器材市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：神經血管介入器材市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Abbott Laboratories
  • Acandis GmbH
  • Achieva Medical Co Ltd
  • Asahi Intecc Co Ltd
  • Balt Group
  • Boston Scientific Corporation
  • Cerus Endovascular Ltd
  • Evasc Neurovascular Enterprises
  • Imperative Care Inc
  • InspireMD Inc
  • Integer Holdings Corporation
  • Kaneka Corporation
  • Lepu Medical Technology Beijing Co Ltd
  • Medtronic plc
  • Merit Medical Systems Inc
  • MicroPort Scientific Corporation
  • NeuroSafe Medical Co Ltd
  • NeuroVasc Technologies Inc
  • Penumbra Inc
  • Perflow Medical Ltd
  • Rapid Medical Ltd
  • Shanghai HeartCare Medical Technology Corporation Ltd
  • Shape Memory Medical Inc
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Vesalio LLC
  • Wallaby Medical
  • Zylox-Tonbridge Medical Technology Co Ltd
Product Code: MRR-ED54C46E8FA1

The Neurovascular Intervention Devices Market is projected to grow by USD 7.14 billion at a CAGR of 6.69% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.53 billion
Estimated Year [2026] USD 4.84 billion
Forecast Year [2032] USD 7.14 billion
CAGR (%) 6.69%

The neurovascular intervention devices landscape is expanding as stroke and intracranial aneurysm care moves from pharmacologic-only treatment toward time-sensitive, image-guided endovascular therapy. The World Stroke Organization and Global Burden of Disease data identify stroke as one of the leading global causes of death and long-term disability, with more than 12 million new strokes and over 6 million stroke-related deaths reported annually. This disease burden supports sustained clinical demand for stent retrievers, aspiration catheters, embolization coils, flow diverters, intrasaccular devices, neurovascular stents, guidewires, microcatheters, balloon catheters, and vascular access systems.

Clinical adoption is underpinned by randomized evidence showing that mechanical thrombectomy improves functional outcomes in eligible large vessel occlusion stroke, including selected patients treated beyond the traditional early treatment window when advanced imaging confirms salvageable brain tissue. Hospitals, device manufacturers, clinicians, and payers are therefore prioritizing faster diagnosis, organized stroke networks, and neurovascular devices that improve deliverability, recanalization, procedural safety, and workflow efficiency.

Transformative Shifts in the Neurovascular Device Landscape

The neurovascular intervention devices landscape is being reshaped by the convergence of minimally invasive therapy, advanced neuroimaging, and formalized stroke systems of care. Mechanical thrombectomy has shifted acute ischemic stroke treatment toward rapid endovascular access for appropriate large vessel occlusion cases, while newer aneurysm technologies such as flow diversion, intrasaccular embolization, and adjunctive stenting are broadening treatment options for complex, bifurcation, and wide-neck intracranial aneurysms.

Regulatory and procurement expectations are also changing. The European Medical Device Regulation has raised clinical evidence, risk management, and post-market surveillance requirements, while U.S. FDA pathways continue to emphasize safety, performance, labeling accuracy, and real-world monitoring. At the same time, hospitals are consolidating neurointerventional services into high-volume comprehensive stroke centers and thrombectomy-capable networks, placing greater value on device compatibility, physician training support, inventory reliability, imaging integration, and measurable clinical outcomes.

Cumulative Impact of Artificial Intelligence in Neurovascular Care

Artificial intelligence is creating a cumulative impact across the neurovascular care pathway rather than acting as a single-point technology. FDA-authorized AI-enabled radiology tools increasingly support detection and triage of large vessel occlusion, intracranial hemorrhage, and perfusion abnormalities, helping care teams shorten door-to-image, image-to-notification, and image-to-intervention decision cycles in acute stroke workflows.

Beyond triage, AI is being applied to vessel segmentation, clot characterization, aneurysm measurement, procedural planning, robotics research, case prioritization, quality reporting, and post-market performance analytics. The strongest commercial opportunities will come from validated AI that integrates with PACS, stroke communication platforms, electronic health records, and cath lab workflows. Industry leaders must also address algorithmic bias, cybersecurity, explainability, data governance, and evidence generation because AI performance can vary across scanners, imaging protocols, patient populations, and clinical settings.

Key Regional Insights: Asia-Pacific, North America, Europe, and Emerging Regions

North America remains a high-adoption region for neurovascular intervention devices due to mature stroke center networks, broad availability of CT angiography and perfusion imaging, established reimbursement channels, and strong participation in neurovascular clinical research. Europe combines sophisticated neurointerventional practice with stricter evidence expectations under the Medical Device Regulation, creating opportunities for clinically differentiated thrombectomy, embolization, and aneurysm treatment technologies that can demonstrate safety, durability, usability, and health-system value.

Asia-Pacific carries a substantial share of the global stroke burden, with China, India, Japan, South Korea, and Australia shaping demand through different combinations of public investment, specialist availability, imaging infrastructure, and reimbursement maturity. Latin America is led by Brazil and Mexico but remains uneven in access to thrombectomy-capable hospitals and trained neurointerventional specialists. The Middle East, particularly advanced Gulf health systems, is investing in tertiary hospitals, digital health, and stroke service modernization, while Africa represents a long-term access opportunity constrained by limited advanced imaging capacity, specialist shortages, referral delays, and affordability barriers.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are moving toward stronger stroke referral pathways and greater adoption of endovascular stroke treatment, but implementation differs widely between Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines because of reimbursement models, urban-rural access, hospital infrastructure, and interventional workforce capacity. GCC countries are investing in tertiary care hospitals, digital health infrastructure, specialist recruitment, and international clinical standards, which supports demand for premium neurovascular technologies in centers of excellence.

The European Union is defined by MDR compliance, stronger clinical evidence expectations, coordinated health technology assessment trends, and sophisticated hospital procurement. BRICS countries represent major procedure-volume potential because of high stroke burden and expanding hospital capacity, but pricing, local manufacturing, public purchasing, and reimbursement inclusion are decisive. G7 markets remain central to innovation, guideline development, clinical trial leadership, and early adoption of advanced neurovascular devices, while NATO countries increasingly frame medical supply resilience, secure procurement, and domestic capacity as healthcare security priorities.

Key Country Insights Across Major Neurovascular Markets

The United States is a leading innovation and adoption hub, supported by comprehensive stroke center certification, FDA-reviewed neurovascular devices, advanced imaging access, and strong clinical trial infrastructure, while Canada emphasizes equitable access across provincial health systems and regionalized stroke care pathways. Mexico and Brazil are expanding neurointerventional capability, though access to mechanical thrombectomy and aneurysm embolization remains concentrated in major urban hospitals and private or tertiary public centers.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine mature specialist networks with increasing scrutiny of clinical evidence, procurement value, and post-market performance, while Russia presents demand shaped by public investment, regional infrastructure differences, and access variability. China is scaling domestic and imported neurovascular technologies alongside high stroke volumes and expanding hospital capabilities; India offers substantial long-term clinical need but remains highly price-sensitive with uneven access outside large metropolitan centers. Japan and South Korea are advanced adopters with strong imaging infrastructure, specialist capacity, and aging populations that increase cerebrovascular disease management needs, while Australia benefits from organized stroke networks, aeromedical referral pathways, and telehealth-enabled coordination across geographically dispersed communities.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence-backed differentiation in neurovascular intervention devices. Products that improve first-pass reperfusion, reduce procedure time, enhance trackability through tortuous anatomy, lower complication risk, and demonstrate durable aneurysm occlusion will command stronger clinical attention than devices positioned only on incremental design changes.

Manufacturers should build integrated offerings around physician training, AI-enabled workflow partnerships, inventory planning, and real-world evidence generation. Commercial teams should segment markets by stroke network maturity, reimbursement readiness, imaging access, and specialist density. In emerging markets, affordability, local partnerships, physician education, service support, and reliable supply chains are critical. Across all regions, leaders should prepare for tighter post-market surveillance, cybersecurity expectations for connected systems, and stronger proof of clinical and health-economic value.

Research Methodology

This executive summary is based on a structured methodology combining verified secondary research, regulatory review, clinical literature assessment, and market triangulation. Sources considered include peer-reviewed stroke and neurointervention studies, World Stroke Organization and Global Burden of Disease findings, FDA and European regulatory information, hospital care pathway standards, reimbursement references, clinical guideline documents, and publicly available healthcare infrastructure indicators.

Insights were validated through cross-checking of disease burden, technology adoption drivers, regulatory trends, care delivery models, and regional healthcare infrastructure indicators. The analysis emphasizes evidence-supported directionality rather than unsupported numerical forecasts, ensuring that conclusions reflect clinically grounded and commercially relevant developments in neurovascular intervention devices.

Conclusion

Neurovascular intervention devices are becoming central to modern stroke and intracranial aneurysm care as health systems prioritize faster diagnosis, minimally invasive treatment, and measurable patient outcomes. The landscape is supported by a large cerebrovascular disease burden, proven thrombectomy benefits in selected large vessel occlusion patients, continued aneurysm device innovation, and growing use of artificial intelligence to accelerate imaging triage and treatment coordination.

Competitive advantage will depend on clinical evidence, procedural performance, regulatory readiness, supply reliability, and the ability to support organized stroke systems across both mature and emerging healthcare markets. Organizations that align product innovation with real-world workflow, physician training, data-driven quality improvement, and access expansion will be best positioned for sustainable growth.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Neurovascular Intervention Devices Market, by Product Type

  • 7.1. Embolic Agents
    • 7.1.1. Liquid Embolics
    • 7.1.2. Particulate Embolics
  • 7.2. Flow Diverters
    • 7.2.1. Pipeline Embolization Device
    • 7.2.2. Surpass Flow Diverter
  • 7.3. Microcatheters
    • 7.3.1. Hydrophilic Coated
    • 7.3.2. Polymer Coated
  • 7.4. Neurovascular Coils
    • 7.4.1. Detachable Coils
    • 7.4.2. Pushable Coils
  • 7.5. Stents
    • 7.5.1. Balloon Mounted
    • 7.5.2. Self Expanding
  • 7.6. Thrombectomy Devices
    • 7.6.1. Aspiration Devices
    • 7.6.2. Stent Retriever

8. Neurovascular Intervention Devices Market, by Indication

  • 8.1. Aneurysm
  • 8.2. Arteriovenous Malformation
  • 8.3. Stroke

9. Neurovascular Intervention Devices Market, by Procedure Type

  • 9.1. Embolization
  • 9.2. Flow Diversion
  • 9.3. Thrombectomy

10. Neurovascular Intervention Devices Market, by End User

  • 10.1. Ambulatory Centers
  • 10.2. Clinics
  • 10.3. Hospitals

11. Neurovascular Intervention Devices Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. North America
  • 11.3. Latin America
  • 11.4. Europe
  • 11.5. Middle East
  • 11.6. Africa

12. Neurovascular Intervention Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Neurovascular Intervention Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Concentration Analysis, 2025
    • 14.1.1. Concentration Ratio (CR)
    • 14.1.2. Herfindahl Hirschman Index (HHI)
  • 14.2. Recent Developments & Impact Analysis, 2025
  • 14.3. Product Portfolio Analysis, 2025
  • 14.4. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Abbott Laboratories
  • 15.2. Acandis GmbH
  • 15.3. Achieva Medical Co Ltd
  • 15.4. Asahi Intecc Co Ltd
  • 15.5. Balt Group
  • 15.6. Boston Scientific Corporation
  • 15.7. Cerus Endovascular Ltd
  • 15.8. Evasc Neurovascular Enterprises
  • 15.9. Imperative Care Inc
  • 15.10. InspireMD Inc
  • 15.11. Integer Holdings Corporation
  • 15.12. Kaneka Corporation
  • 15.13. Lepu Medical Technology Beijing Co Ltd
  • 15.14. Medtronic plc
  • 15.15. Merit Medical Systems Inc
  • 15.16. MicroPort Scientific Corporation
  • 15.17. NeuroSafe Medical Co Ltd
  • 15.18. NeuroVasc Technologies Inc
  • 15.19. Penumbra Inc
  • 15.20. Perflow Medical Ltd
  • 15.21. Rapid Medical Ltd
  • 15.22. Shanghai HeartCare Medical Technology Corporation Ltd
  • 15.23. Shape Memory Medical Inc
  • 15.24. Stryker Corporation
  • 15.25. Teleflex Incorporated
  • 15.26. Terumo Corporation
  • 15.27. Vesalio LLC
  • 15.28. Wallaby Medical
  • 15.29. Zylox-Tonbridge Medical Technology Co Ltd

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL EMBOLIC AGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL EMBOLIC AGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL EMBOLIC AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LIQUID EMBOLICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LIQUID EMBOLICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LIQUID EMBOLICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PARTICULATE EMBOLICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PARTICULATE EMBOLICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PARTICULATE EMBOLICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FLOW DIVERTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FLOW DIVERTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PIPELINE EMBOLIZATION DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PIPELINE EMBOLIZATION DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PIPELINE EMBOLIZATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURPASS FLOW DIVERTER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURPASS FLOW DIVERTER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURPASS FLOW DIVERTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MICROCATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MICROCATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MICROCATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HYDROPHILIC COATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HYDROPHILIC COATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HYDROPHILIC COATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL POLYMER COATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL POLYMER COATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL POLYMER COATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEUROVASCULAR COILS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROVASCULAR COILS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NEUROVASCULAR COILS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DETACHABLE COILS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DETACHABLE COILS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DETACHABLE COILS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PUSHABLE COILS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PUSHABLE COILS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PUSHABLE COILS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BALLOON MOUNTED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BALLOON MOUNTED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BALLOON MOUNTED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SELF EXPANDING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SELF EXPANDING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SELF EXPANDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ASPIRATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ASPIRATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ASPIRATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL STENT RETRIEVER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL STENT RETRIEVER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL STENT RETRIEVER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ANEURYSM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANEURYSM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTERIOVENOUS MALFORMATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ARTERIOVENOUS MALFORMATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTERIOVENOUS MALFORMATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL STROKE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL STROKE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL STROKE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL EMBOLIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL EMBOLIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FLOW DIVERSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FLOW DIVERSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FLOW DIVERSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL THROMBECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL THROMBECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL THROMBECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AMBULATORY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AMBULATORY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AMBULATORY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. GCC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. GCC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. GCC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 169. GCC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
  • TABLE 170. GCC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2032 (USD MILLION)
  • TABLE 171. GCC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 172. GCC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 173. GCC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 174. GCC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 175. GCC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. GCC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. G7 NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. G7 NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. G7 NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 202. G7 NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
  • TABLE 203. G7 NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2032 (USD MILLION)
  • TABLE 204. G7 NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 205. G7 NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 206. G7 NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 207. G7 NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 208. G7 NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. G7 NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. NATO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 211. NATO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. NATO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 213. NATO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
  • TABLE 214. NATO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2032 (USD MILLION)
  • TABLE 215. NATO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 216. NATO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 217. NATO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 218. NATO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 219. NATO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. NATO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 236. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
  • TABLE 237. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2032 (USD MILLION)
  • TABLE 238. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 239. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 240. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 241. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 242. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 247. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
  • TABLE 248. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2032 (USD MILLION)
  • TABLE 249. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 250. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 251. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 252. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 253. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 256. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 258. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
  • TABLE 259. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2032 (USD MILLION)
  • TABLE 260. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 261. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 262. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 263. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 264. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 280. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
  • TABLE 281. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2032 (USD MILLION)
  • TABLE 282. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 283. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 284. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 285. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 286. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 289. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 291. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
  • TABLE 292. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2032 (USD MILLION)
  • TABLE 293. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 294. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 295. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 296. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 297. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 299. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 300. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 302. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
  • TABLE 303. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2032 (USD MILLION)
  • TABLE 304. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 305. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 306. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 307. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 308. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 310. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 311. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 313. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
  • TABLE 314. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROCATHETERS, 2018-2032 (USD MILLION)
  • TABLE 315. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 316. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 317. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 318. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 319. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 321. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 322. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 323. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 324. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)